Michele Romanow Teams Up with Science&Humans for Hormone Wellness

Michele Romanow, renowned Dragon's Den investor and entrepreneurial powerhouse, has joined forces with Science&Humans, an innovative hormone wellness platform revolutionizing personalized clinical support throughout Canada.

This collaboration unites Romanow's extensive business expertise and influential platform with Science&Humans' commitment to providing scientifically-validated hormone care through accessible digital channels. By leveraging joint content initiatives and targeted outreach, Romanow will champion greater understanding of comprehensive hormone wellness options, spanning fertility management to metabolic optimization and menopause care.

“We are thrilled to announce our investment in Science&Humans, a company building an integrated platform for hormone health through at-home diagnostics, virtual clinical consults and vertically integrated pharmacy experience. The investment comes as part of a Series A financing that we led with participation from WELL health, Michele Romanow and a group of US-based family offices and clinicians.”

— Pender Ventures

As a celebrated Canadian business leader and venture capitalist, Michele Romanow has gained widespread recognition through her prominent position on Dragon's Den. Her impressive portfolio reflects a commitment to supporting technology-driven, data-centric enterprises that address significant challenges with meaningful impact. Her dedication to healthcare transformation and scalable digital infrastructure positions her perfectly alongside Science&Humans, whose comprehensive hormone wellness model resonates with her emphasis on research-backed interventions and democratized healthcare access. This alliance enables Romanow to contribute strategic vision and public advocacy to an initiative focused on reimagining hormone care delivery and broadening availability of reliable medical guidance.

Science&Humans operates as a fully integrated hormone wellness ecosystem committed to transforming how individuals comprehend and address hormone-driven health challenges. Through convenient home testing, remote medical consultations and streamlined pharmaceutical services, this platform assists people managing diverse concerns including hormonal dysregulation, reproductive planning, perimenopausal transitions and menopausal symptoms, metabolic wellness and testosterone therapy. Additionally, the organization collaborates with corporate clients and insurance providers to deliver hormone care solutions across broader populations.

“Science&Humans has built a differentiated, evidence-based platform for hormone care—an area that has been historically underdiagnosed and underserved.”

— Meryeme Lahmami, principal at Pender Ventures

Romanow's engagement will bolster Science&Humans throughout its ongoing expansion of clinical offerings and outreach to diverse communities seeking credible, medically sound care. This joint effort strives to normalize dialogue surrounding hormone wellness while highlighting empowering solutions that enable individuals to manage their health proactively.

Through Michele Romanow's strategic partnership, Science&Humans stands ready to fast-track its commitment to accessible, scientifically rigorous hormone care, supporting people in achieving healthier, more harmonious lives.